Clinical Trial Update: An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years

View source ↗

Summary

An observational study of HER2-positive metastatic or locally advanced breast cancer patients treated with trastuzumab (Herceptin) as first-line therapy who rem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2016-02-24